J C Hageman

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Vancomycin-intermediate Staphylococcus aureus in a home health-care patient
    J C Hageman
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:1023-5. 2001
  2. ncbi Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants
    Jeffrey C Hageman
    Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA
    Clin Infect Dis 43:e42-5. 2006
  3. ncbi Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season
    Jeffrey C Hageman
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 12:894-9. 2006
  4. ncbi Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus
    Jeffrey C Hageman
    Centers for Disease Control and Prevention, Atlanta, GA 30033, USA
    Diagn Microbiol Infect Dis 62:440-2. 2008
  5. ncbi A clone of methicillin-resistant Staphylococcus aureus among professional football players
    Sophia V Kazakova
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Atlanta, GA 30333, USA
    N Engl J Med 352:468-75. 2005
  6. ncbi Methicillin-resistant Staphylococcus aureus disease in three communities
    Scott K Fridkin
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 352:1436-44. 2005
  7. ncbi Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003
    Concepcion F Estivariz
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA 30333, USA
    J Infect 54:349-57. 2007
  8. ncbi Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006
    Dawn M Sievert
    Michigan Department of Community Health, Lansing, USA
    Clin Infect Dis 46:668-74. 2008
  9. ncbi No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001
    Henry C Baggett
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA
    Clin Infect Dis 41:991-7. 2005
  10. ncbi Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
    Soju Chang
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta 30333, USA
    N Engl J Med 348:1342-7. 2003

Detail Information

Publications12

  1. ncbi Vancomycin-intermediate Staphylococcus aureus in a home health-care patient
    J C Hageman
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:1023-5. 2001
    ..The patient was treated successfully with antimicrobial therapy, biliary drainage, and reconstruction. Standard precautions in the home health setting appear successful in preventing transmission...
  2. ncbi Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants
    Jeffrey C Hageman
    Centers for Disease Control and Prevention, Atlanta, Georgia 30033, USA
    Clin Infect Dis 43:e42-5. 2006
    ....
  3. ncbi Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season
    Jeffrey C Hageman
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 12:894-9. 2006
    ..In communities with a high prevalence of MRSA, empiric therapy of severe CAP during periods of high influenza activity should include consideration for MRSA...
  4. ncbi Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus
    Jeffrey C Hageman
    Centers for Disease Control and Prevention, Atlanta, GA 30033, USA
    Diagn Microbiol Infect Dis 62:440-2. 2008
    ..Development of the VISA phenotype does not appear limited to traditional health care strains of S. aureus...
  5. ncbi A clone of methicillin-resistant Staphylococcus aureus among professional football players
    Sophia V Kazakova
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Atlanta, GA 30333, USA
    N Engl J Med 352:468-75. 2005
    ..We investigated an outbreak of abscesses due to MRSA among members of a professional football team and examined the transmission and microbiologic characteristics of the outbreak strain...
  6. ncbi Methicillin-resistant Staphylococcus aureus disease in three communities
    Scott K Fridkin
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 352:1436-44. 2005
    ..Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. The national burden and clinical effect of this novel presentation of MRSA disease are unclear...
  7. ncbi Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003
    Concepcion F Estivariz
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA 30333, USA
    J Infect 54:349-57. 2007
    ..We conducted a retrospective study to determine trends and characteristics of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in Hawaii...
  8. ncbi Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006
    Dawn M Sievert
    Michigan Department of Community Health, Lansing, USA
    Clin Infect Dis 46:668-74. 2008
    ....
  9. ncbi No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001
    Henry C Baggett
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA
    Clin Infect Dis 41:991-7. 2005
    ..anthracis infection. We hypothesized that early antibiotic use could have decreased the sensitivity of diagnostic tests or that bioterrorism-related inhalational anthrax may include mild disease...
  10. ncbi Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
    Soju Chang
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta 30333, USA
    N Engl J Med 348:1342-7. 2003
  11. ncbi Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility
    William E Trick
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Am Geriatr Soc 52:2003-9. 2004
    ....
  12. ncbi Antimicrobial proficiency testing of National Nosocomial Infections Surveillance System hospital laboratories
    Jeffrey C Hageman
    Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Infect Control Hosp Epidemiol 24:356-61. 2003
    ..Disk diffusion continues to be unreliable for vancomycin testing of staphylococci and must be used cautiously for enterococci. Further education on the processing of ESbetaL-producing organisms is warranted...